MFDS — authorised 1 September 1977
- Marketing authorisation holder: GD SEARLE LLC
- Status: likely_approved
🇰🇷 Norpace Cr in South Korea
MFDS authorised Norpace Cr on 1 September 1977
Marketing authorisation
Norpace Cr in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Cardiovascular approved in South Korea
Frequently asked questions
Is Norpace Cr approved in South Korea?
Yes. MFDS authorised it on 1 September 1977.
Who is the marketing authorisation holder for Norpace Cr in South Korea?
GD SEARLE LLC holds the South Korean marketing authorisation.